Publications by authors named "Clement Bailly"

Claim this Profile
P
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.
Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, Aurore Perrot, Cyrille Hulin, Clément Bailly

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinoma.
Killian Véron, Etienne Becht, Astrid Laurent-Bellue, Rémy Nicolle, Miguel Albuquerque, Clément Bailly

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of PET Quantification for Prognosis and Treatment Response Monitoring.
Ronan Abgral, Clément Bailly, Ronald Boellaard, David Bourhis, Thomas Carlier

PET Clin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.
Solène Malmon, Mad-Helenie Elsensohn, Catherine Thieblemont, Franck Morschhauser, Olivier Casasnovas, Clement Bailly

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation protection considerations with [Zr]Zr-girentuximab PET and surgery.
Adnan Chowdhury, Clément Morgat, Clement Bailly, John Sunderland, Stephen A Graves

EJNMMI Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-based lesion graphs meet clinical data: An interpretable cross-attention framework for DLBCL treatment response prediction.
Oriane Thiery, Mira Rizkallah, Clément Bailly, Caroline Bodet-Milin, Emmanuel Itti

Comput Med Imaging Graph· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between Y-PET/CT(MR)-estimated activity and dose calibrator measured administered activity: an international study in SIRT patients treated with resin and glass microspheres.
Thomas Carlier, Silvano Gnesin, Justin K Mikell, Maurizio Conti, John O Prior, Clément Bailly

EJNMMI Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
Brian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, Michael A Morris, Viraj Master, Clement Bailly

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Clément Bailly

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[First-line management of infertile couple. Guidelines for clinical practice of the French College of Obstetricians and Gynecologists 2022].
Charlotte Sonigo, Geoffroy Robin, Florence Boitrelle, Eloïse Fraison, Nathalie Sermondade, Clément Bailly

Gynecol Obstet Fertil Senol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?
Juliette Boilève, Valentine Guimas, Arthur David, Clément Bailly, Yann Touchefeu

Curr Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
Arnaud Dieudonné, Clément Bailly, Florent Cachin, Agathe Edet-Sanson, Françoise Kraeber-Bodéré

Eur J Nucl Med Mol Imaging· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
Thomas Carlier, Gauthier Frécon, Diana Mateus, Mira Rizkallah, Françoise Kraeber-Bodéré, Clément Bailly

J Nucl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Clément Bailly

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, Clément Bailly

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Caroline Bodet-Milin, Cyrille Morvant, Thomas Carlier, Gauthier Frecon, Olivier Tournilhac, Clément Bailly

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid simultaneous whole-body 2-[F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.
Bastien Jamet, Thomas Carlier, Clément Bailly, Caroline Bodet-Milin, Aurélien Monnet

Eur Radiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group.
Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Clement Bailly

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosis.
Giorgio Treglia, Clément Bailly

Front Med (Lausanne)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study.
Françoise Kraeber-Bodéré, Sonja Zweegman, Aurore Perrot, Cyrille Hulin, Denis Caillot, Clément Bailly

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma.
Clément Bailly, Thomas Carlier, Benoit Tessoulin, Thomas Gastinne, Françoise Kraeber-Bodere

Hematol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-PET: Design options and clinical proof-of-concept.
Alexandre Lugat, Clément Bailly, Michel Chérel, Caroline Rousseau, Françoise Kraeber-Bodéré

Front Med (Lausanne)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Signature of F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study.
Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Clément Bailly

J Nucl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
Etienne Garin, Jean-Baptiste Pinaquy, Clement Bailly, Christian Sengel, Denis Mariano-Goulart

Cardiovasc Intervent Radiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT in Lymphoma: Where Do We Go Now?
Yassine Al Tabaa, Clement Bailly, Salim Kanoun

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis